Zobrazeno 1 - 10
of 2 170
pro vyhledávání: '"Mannelli, F."'
Autor:
Scicutella, F., Cucu, M.A., Mannelli, F., Pastorelli, R., Daghio, M., Paoli, P., Pazzagli, L., Turini, L., Mantino, A., Luti, S., Genovese, M., Viti, C., Buccioni, A.
Publikováno v:
In animal June 2023 17(6)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Coltro G; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence., Capecchi G; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence., Maffioli M; Hematology Unit, ASST Sette Laghi, Ospedale di Circolo, Varese., Mannelli F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence., Mora B; Hematology Division, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan., Atanasio A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence., Iurlo A; Hematology Division, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan., Maccari C; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence., Farina M; Hematology Unit, ASST Spedali Civili di Brescia, Brescia., Nacca E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence., Caramella M; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan., Signori L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence., Borella M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence., Bertù L; Department of Medicine and Surgery, University of Insubria, Varese., Esposito M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence., Guglielmelli P; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence., Passamonti F; Hematology Division, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan., Vannucchi AM; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence. a.vannucchi@unifi.it.
Publikováno v:
Haematologica [Haematologica] 2024 Oct 01; Vol. 109 (10), pp. 3398-3403. Date of Electronic Publication: 2024 Oct 01.
Autor:
Ciolli G; Department of Experimental and Clinical Medicine, University of Florence, Largo Giovanni Alessandro Brambilla 3, Florence 50134, Italy., Pasquini A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Mannelli F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy., Scappini B; Haematology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Gianfaldoni G; Haematology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Quinti E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Fasano L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Caroprese J; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Crupi F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Vannucchi AM; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.; Haematology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Piccini M; Haematology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
Publikováno v:
Therapeutic advances in hematology [Ther Adv Hematol] 2024 Sep 23; Vol. 15, pp. 20406207241270846. Date of Electronic Publication: 2024 Sep 23 (Print Publication: 2024).
Autor:
Ciolli G; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Piccini M; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Mannelli F; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Gianfaldoni G; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Scappini B; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Fasano L; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Crupi F; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Quinti E; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Pasquini A; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Caroprese J; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence., Rotunno G; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Pancani F; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Signori L; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Maccari C; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Vanderwert FI; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Guglielmelli P; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence., Vannucchi AM; Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence. amvannucchi@unifi.it.
Publikováno v:
Haematologica [Haematologica] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.
Autor:
Tanasi I; Unità Operativa di Ematologia, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy. Electronic address: ilaria.tanasi@aovr.veneto.it., Crosera L; Unità Operativa di Ematologia, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Taus F; Department of Diagnostic and Public Health, Section of Epidemiology and Medical Statistics, University of Verona, Verona, Italy., Orsolini G; Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Unità Operativa di Reumatologia, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Adami G; Unità Operativa di Reumatologia, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Olivieri F; Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Unità Operativa di Allergologia e Asma Center, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Bernardelli A; Unità Operativa di Ematologia, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Bonadonna P; Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Unità Operativa di Allergologia e Asma Center, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Nalin F; Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Unità Operativa di Allergologia e Asma Center, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Sella S; Clinica Medica 1, Azienda Ospedale Università di Padova, Padova, Italy., Giannini S; Clinica Medica 1, Azienda Ospedale Università di Padova, Padova, Italy., Liu Y; Translational Allergic Immunopathology Unit, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA., Mannelli F; CRIMM, Centro di Ricerca e Innovazione per le Malattie Mieloproliferative, Università di Firenze, Dipartimento di Medicina Sperimentale e Clinica, Denothe Excellence Center, Università degli Studi di Firenze, Firenze, Italy., Vanderwert F; CRIMM, Centro di Ricerca e Innovazione per le Malattie Mieloproliferative, Università di Firenze, Dipartimento di Medicina Sperimentale e Clinica, Denothe Excellence Center, Università degli Studi di Firenze, Firenze, Italy., Bonifacio M; Unità Operativa di Ematologia, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona, Verona, Italy., Krampera M; Unità Operativa di Ematologia, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona, Verona, Italy., Rossini M; Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Unità Operativa di Reumatologia, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Lyons JJ; Translational Allergic Immunopathology Unit, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA., Zanotti R; Gruppo Interdisciplinare per lo Studio della Mastocitosi (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
Publikováno v:
Bone [Bone] 2024 Sep; Vol. 186, pp. 117141. Date of Electronic Publication: 2024 May 31.
Autor:
Guglielmelli P; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Mora B; S.C. Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Gesullo F; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Mannelli F; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Loscocco GG; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Signori L; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Pessina C; Laboratory of Cytogenetics and Molecular Biology, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy., Colugnat I; Laboratory of Cytogenetics and Molecular Biology, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy., Aquila R; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Balliu M; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Maccari C; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Romagnoli S; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Paoli C; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Nacca E; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Fagiolo L; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy., Maffioli M; S.C. Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Barbui T; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., Passamonti F; S.C. Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Dipartimento di Oncologia ed Onco-Ematologia, Università degli Studi di Milano, Milan, Italy., Vannucchi AM; CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, DMSC, University of Florence, AOU Careggi, Florence, Italy.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Aug; Vol. 99 (8), pp. 1550-1559. Date of Electronic Publication: 2024 Jun 06.
Autor:
Sciumè M; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Serpenti F; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Zanotti R; Section of Hematology, Department of Medicine, Verona University Hospital, Verona, Italy., Bonadonna P; Allergy Unit, Verona University Hospital, Verona, Italy., Tanasi I; Section of Hematology, Department of Medicine, Verona University Hospital, Verona, Italy., Crosera L; Section of Hematology, Department of Medicine, Verona University Hospital, Verona, Italy., Elena C; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Mannelli F; SOD Ematologia, CRIMM (Center Research and Innovation of Myeloproliferative Neoplasms), Università degli Studi di Firenze, Florence, Italy., Crupi F; SOD Ematologia, CRIMM (Center Research and Innovation of Myeloproliferative Neoplasms), Università degli Studi di Firenze, Florence, Italy., Papayannidis C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'L. & A. Seràgnoli', Bologna, Italy., Sartor C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'L. & A. Seràgnoli', Bologna, Italy., Soverini S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'L. & A. Seràgnoli', Bologna, Italy., Rondoni M; Hematology Unit, Azienda USL della Romagna, Ravenna, Italy., Eller-Vainicher C; Endocrinology and Diabetology Units, Department of Medical Sciences and Community, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Pravettoni V; Department of Internal Medicine, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy., Rivolta F; Department of Internal Medicine, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy., Alberti Violetti S; Dermatology Unit, Department of Physiopathology and Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Croci GA; Division of Pathology, Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Migliorini AC; Settore di Ematologia, Laboratorio Analisi, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Bolli N; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Giannarelli D; Facility of Epidemiology and Biostatistics, GSTeP, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy., Grifoni FI; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Publikováno v:
Hematological oncology [Hematol Oncol] 2024 May; Vol. 42 (3), pp. e3277.
Autor:
Innocenti R, Rigacci L, Restelli U, Scappini B, Gianfaldoni G, Fanci R, Mannelli F, Scolari F, Croce D, Bonizzoni E, Perrone T, Bosi A
Publikováno v:
Journal of Blood Medicine, Vol Volume 10, Pp 21-27 (2018)
Rolando Innocenti,1 Luigi Rigacci,1,2 Umberto Restelli,3,4 Barbara Scappini,1 Giacomo Gianfaldoni,1 Rosa Fanci,1 Francesco Mannelli,1 Francesca Scolari,3 Davide Croce,3,4 Erminio Bonizzoni,5 Tania Perrone,6 Alberto Bosi1 1Hematology Department, Unive
Externí odkaz:
https://doaj.org/article/7a5d87e0fd074032ba18c73c02906d05
Autor:
Tefferi A; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., Loscocco GG; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Farrukh F; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., Szuber N; Department of Hematology, Université de Montréal, Quebec, Canada., Mannelli F; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Pardanani A; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., Hanson CA; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., Ketterling RP; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., De Stefano V; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Rome, Italy., Carobbio A; FROM esearch Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., Barbui T; FROM esearch Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., Guglielmelli P; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Gangat N; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., Vannucchi AM; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Dec; Vol. 98 (12), pp. 1829-1837. Date of Electronic Publication: 2023 Sep 04.